Normalization of hemoglobin level in patients with chronic kidney disease and anemia - Wikidata - wikimedia - TriplyDB

Normalization of hemoglobin level in patients with chronic kidney disease and anemia

Normalization of hemoglobin level in patients with chronic kidney disease and anemia

http://www.wikidata.org/entity/Q28274269

about

Recombinant human erythropoietin versus placebo or no treatment for the anaemia of chronic kidney disease in people not requiring dialysis Early versus delayed erythropoietin for the anaemia of end-stage kidney disease Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis Short-acting erythropoiesis-stimulating agents for anaemia in predialysis patients Early versus delayed erythropoietin for the anaemia of end-stage kidney disease Darbepoetin for the anaemia of chronic kidney disease Interventions for post-transplant anaemia in kidney transplant recipients Continuous erythropoiesis receptor activator (CERA) for the anaemia of chronic kidney disease Erythropoiesis-stimulating agents for anaemia in chronic heart failure patients Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patients Interpreting Results of Clinical Trials: A Conceptual Framework Anemia of chronic disease: a harmful disorder or an adaptive, beneficial response?Guidelines for the management of chronic kidney disease Laboratory use of hepcidin in renal transplant recipients Endothelin Heart failure in patients with chronic kidney disease: a systematic integrative review Recent advances in the management of hemodialysis patients: a focus on cardiovascular disease Towards erythropoietin equations that estimate oxygen delivery rather than static hemoglobin targets Hemoglobin targets for chronic kidney disease patients with anemia: a systematic review and meta-analysis Evidence for the prevention and treatment of stroke in dialysis patients Does AKI truly lead to CKD?FGF23 antagonism: the thin line between adaptation and maladaptation in chronic kidney disease.Considerations and challenges in defining optimal iron utilization in hemodialysis HIF prolyl hydroxylase inhibitors for anemia Relationship between Hemoglobin Levels Corrected by Interdialytic Weight Gain and Mortality in Japanese Hemodialysis Patients: Miyazaki Dialysis Cohort Study Severity of Anemia Predicts Hospital Length of Stay but Not Readmission in Patients with Chronic Kidney Disease: A Retrospective Cohort Study Switching patients with non-dialysis chronic kidney disease from oral iron to intravenous ferric carboxymaltose: effects on erythropoiesis-stimulating agent requirements, costs, hemoglobin and iron status Understanding measurements of vitality in patients with chronic kidney disease: connecting a quality-of-life scale to daily activities Safety of intravenous iron in hemodialysis patients.A Genetic Biomarker of Oxidative Stress, the Paraoxonase-1 Q192R Gene Variant, Associates with Cardiomyopathy in CKD: A Longitudinal Study Mortality associated with dose response of erythropoiesis-stimulating agents in hemodialysis versus peritoneal dialysis patients.Observational studies versus randomized controlled trials: avenues to causal inference in nephrology.Serum erythropoietin level and mortality in kidney transplant recipients Treating anemia in older adults with heart failure with a preserved ejection fraction with epoetin alfa: single-blind randomized clinical trial of safety and efficacy.Higher doses of erythropoietin-stimulating agents and hyporesponsiveness to their effects are associated with increased mortality among prevalent hemodialysis patients.The effect of erythropoietin on exercise capacity, left ventricular remodeling, pressure-volume relationships, and quality of life in older patients with anemia and heart failure with preserved ejection fraction.Form CMS-2728 data versus erythropoietin claims data: implications for quality of care studies.Comparative short-term safety of bolus versus maintenance iron dosing in hemodialysis patients: a replication study.Exploring the effect of erythropoietin on mortality using USRDS data.Anemia is a predictor of graft loss but not cardiovascular events and all-cause mortality in renal transplant recipients: follow-up data from the ALERT study.

P2860

Q24186430-CD6BCA79-8151-46F4-BC57-B0248C783B54 Q24187089-2FBCA421-D4FB-4AD5-A8B5-18B40BC8A236 Q24187413-9048C163-0D39-4D85-B153-2659F17F5B8C Q24188190-10AA4AA8-032D-470F-A68C-C455207D18A7 Q24194838-FD8B3632-BBC8-40F0-A8B5-0D817C4C239B Q24197780-657416AE-00C5-42D8-BB48-B2565A975E02 Q24201134-04AEAD78-AC20-4CF0-9346-3003A37CDF60 Q24202919-D2EF9C91-8400-424D-8E7A-9B19DD219ACB Q24241045-8769F7CB-FA93-46E7-982F-8A30898745A4 Q24246372-84F77BE1-B50A-4147-B633-2B0B1EE2FA4B Q24273399-0E809E81-F7C5-473A-B9C1-D90731D65442 Q24651385-8764C637-8503-4A11-84DD-D5555DB58137 Q24657844-F72C8A2D-A330-4525-8BE3-3B8C5344CE4A Q26765316-8A1F5EE2-A9AF-4AF8-901F-18B1251E3F35 Q26767156-AF65B85C-D7CE-46D9-9610-FD1391EE3CF9 Q26824149-1C0652F9-9A70-4035-A816-5EE88005E3D5 Q26849298-7C737A0D-14EE-44A2-841F-837E32967B75 Q26849406-E334B424-9ABD-417F-87FF-BD8A517D9DCB Q27023213-A599C044-97CF-4D46-A536-EBDA513B6A13 Q27023274-E67FD433-7A45-4416-95AF-5AEE5D3FDCA0 Q27024744-79D7BD02-C3D2-44EA-BD83-2BC9CB4F126E Q27687769-51FF6931-7B62-4B65-83DE-C4A29464FF59 Q28088564-1DD5EB6A-A2BF-4AD3-B00A-178F94682CFF Q28307377-032A1A8B-6320-4E23-86EA-155DB52E7197 Q28468446-B60DEF8E-899F-4D03-9655-378270CDC087 Q28646953-1C47B2ED-2A25-4E8C-B66E-579A14C2D01C Q28648176-3FAE32F7-6707-436E-8999-A7B4AF5009DF Q28727189-1B2B7D09-6912-4B30-88C3-BA4BD9940EED Q30234981-7A62FD60-18F5-4E34-82DE-CC1B01AADF52 Q30381312-3F03AA0E-D4CC-42DA-B071-FB21864FC80E Q30422508-CDF5D462-23E1-47B8-8972-484E5E50C77D Q30423049-B6F83A2D-7371-44C9-B884-A6F9110DB061 Q30423606-7364A2A1-BD5C-4759-BA07-19FFA7993654 Q30442221-3B010ECE-430D-422C-B72B-DCD11EB9537D Q30456721-A9F3A574-F142-4A98-9597-8F7929EF8351 Q30475623-D2C63CBD-7E0E-4427-B0A0-31DC79D148B2 Q30580993-FD9FE6BB-C967-480E-B4E0-4E5C41C6D171 Q30588674-FA828D7F-0597-4E31-922A-5CE346D81845 Q30620811-603BE3A5-47B1-4B5E-AA67-830019655AAF Q30664256-9DF6B479-8820-467B-879F-F1088EEE8E3E

P2860

Normalization of hemoglobin level in patients with chronic kidney disease and anemia

http://www.wikidata.org/entity/Q28274269

description

2006 nî lūn-bûn

@nan

2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

name

Normalization of hemoglobin level in patients with chronic kidney disease and anemia

@ast

Normalization of hemoglobin level in patients with chronic kidney disease and anemia

@en

Normalization of hemoglobin level in patients with chronic kidney disease and anemia

@nl

type

label

Normalization of hemoglobin level in patients with chronic kidney disease and anemia

@ast

Normalization of hemoglobin level in patients with chronic kidney disease and anemia

@en

Normalization of hemoglobin level in patients with chronic kidney disease and anemia

@nl

prefLabel

Normalization of hemoglobin level in patients with chronic kidney disease and anemia

@ast

Normalization of hemoglobin level in patients with chronic kidney disease and anemia

@en

Normalization of hemoglobin level in patients with chronic kidney disease and anemia

@nl

P1433

Q28274269-FE93E925-051C-476F-812D-029C241794DD

P1476

Q28274269-52A0848C-9F61-49F6-BA9C-710596F59591

P2093

Q28274269-08ECF147-9351-4150-AFA1-7405E1BDED8E

Q28274269-124C67BC-20D3-4498-BEEA-41E7057F5E27

Q28274269-1BD86482-0270-4C85-A826-F1C24B979320

Q28274269-3B41F2DF-A1FF-4AA5-BF0D-CCADF695F36D

Q28274269-588FBC57-E8FE-4EDC-AF32-4E0448849C61

Q28274269-8F411327-6B60-4217-A922-2807EAD50AAE

Q28274269-B4A8C4EC-38B8-4C4A-AB9B-7C30931E30A4

P304

Q28274269-8D39229E-3CE2-47BB-AF45-4D7B871ACA80

P31

Q28274269-76E6AEB7-8AFE-465F-8276-4B9BCE4C32A2

P3181

Q28274269-53F4296A-8100-442E-BD35-7DE6DA35E666

P356

Q28274269-F8C4A43D-2B5C-42A6-9557-51824D97B0DD

P407

Q28274269-8ACC9FE6-AC6E-45CF-BF64-5BC2AFE95132

P433

Q28274269-EA0B350C-C49A-43A2-BE16-863806871CD2

P478

Q28274269-8D8A9894-7805-4002-AAC8-7BD1671D7F74

P50

Q28274269-BD05BA62-45EB-483E-A478-A1AE7E2854DF

Q28274269-D04F07FA-342C-4539-B5A4-194AC9C610B3

P577

Q28274269-17624B39-FC85-4D9E-A2FF-6ED5539341B6

P698

Q28274269-C9FE25C5-18C7-4800-800E-2BAF049E1FF0

P921

Q28274269-071BC7E9-EA95-4230-909D-40EBA2F99ABF

P3181

P356

P1433

The New England Journal of Medicine

P1476

Normalization of hemoglobin level in patients with chronic kidney disease and anemia

@en

P2093

Armin Scherhag

http://www.w3.org/2001/XMLSchema#string

CREATE Investigators

http://www.w3.org/2001/XMLSchema#string

Dimitrios Tsakiris

http://www.w3.org/2001/XMLSchema#string

Francesco Locatelli

http://www.w3.org/2001/XMLSchema#string

Hans-Ulrich Burger

http://www.w3.org/2001/XMLSchema#string

Iain C Macdougall

http://www.w3.org/2001/XMLSchema#string

Kai-Uwe Eckardt

http://www.w3.org/2001/XMLSchema#string

P304

2071-2084

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

100058

http://www.w3.org/2001/XMLSchema#string

P356

10.1056/NEJMOA062276

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

355

http://www.w3.org/2001/XMLSchema#string

P50

Tilman B Drueke

P577

2006-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17108342

http://www.w3.org/2001/XMLSchema#string

P921